Jubilant Pharmova Ltd share price logo

Jubilant Pharmova Share Price

(JUBLPHARMA)

₹991.05▲2.33%

as on 04:01PM, 20 Feb 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Jubilant Pharmova Performance

  • Day's Low

    Day's High

    ₹959.3
    Day's Price Range
    ₹1,004.45

  • 52 Week's Low

    52 Week's High

    ₹538.05
    52-Week Price Range
    ₹1,309.9
1 Month Return-1.39 %
3 Month Return-14.32 %
1 Year Return+ 61.19 %
Previous Close₹968.45
Open₹960.10
Volume1.40L
Upper Circuit-
Lower Circuit-
Market Cap₹15,427.41Cr

Jubilant Pharmova Key Statistics

P/E Ratio

24.46

PEG Ratio

0.66

Market Cap

₹15,427.41 Cr

P/B Ratio

3.81

EPS

4.6

Dividend Yield

0.88

Sector

Pharmaceuticals

ROE

1.32

Jubilant Pharmova Analyst Rating

based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts offering long term price targets for Jubilant Pharmova. An average target of ₹1310

Source: S&P Global Market Intelligence

Jubilant Pharmova Share analysis

Jubilant Pharmova price forecast by 2 analysts

Upside of35.27%

High

₹1385

Target

₹1310.00

Low

₹1235

Jubilant Pharmova target price ₹1310, a slight upside of 35.27% compared to current price of ₹991.05. According to 2 analysts rating.

Source: S&P Global Market Intelligence

Key events for Jubilant Pharmova Ltd

  • Jubilant Pharmova Sees Strong Q3 Profit Growth - 31 Jan, 2025

    Jubilant Pharmova's Q3 profit surged 51% to Rs 101 crore, fueled by robust demand for radiopharmaceuticals. Revenue increased by 9%, with the segment contributing significantly to overall earnings.

  • Jubilant Subsidiary Acquires Majority Stake in JASMIN - 29 Jan, 2025

    Jubilant Pharmova's subsidiary, Jubilant Biosys, has acquired an 80% stake in JASMIN, a new company in France, to strengthen its R&D presence. The acquisition is not subject to foreign investment control in France, and JASMIN will take over Pierre Fabre's R&D center in Saint Julien.

  • Jubilant Pharmova Faces USFDA Observations Impact - 17 Jan, 2025

    Jubilant Pharmova's subsidiary, Jubilant Cadista Pharmaceuticals, received five observations from the USFDA during an inspection, leading to a 2% drop in shares. The facility has ceased manufacturing operations since April 2024.

Insights on Jubilant Pharmova Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, JUBLPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 3.06% to 3.64% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, JUBLPHARMA stock has moved up by 0.8%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 1.77K Cr → 1.83K Cr (in ₹), with an average increase of 3.1% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 135.1% return, outperforming this stock by 12.5%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 50.68% of holdings in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 17.94% to 16.96% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 482.1 Cr → 100.9 Cr (in ₹), with an average decrease of 40.3% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 25.17% to 24.83% in Dec 2024 quarter

Jubilant Pharmova Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹1,665.20Cr (-)₹1,746.40Cr (↑4.88%)₹1,720.40Cr (↓1.49%)₹1,742.20Cr (↑1.27%)₹1,813.70Cr (↑4.10%)
Net Income₹66.40Cr (-)-₹61.80Cr (↓193.07%)₹481.80Cr (↓879.61%)₹102.50Cr (↓78.73%)₹100.70Cr (↓1.76%)
Net Profit Margin3.99% (-)-3.54% (↓188.72%)28.01% (↓891.24%)5.88% (↓79.01%)5.55% (↓5.61%)
Value in ₹ crore
Details2021202220232024
Total Assets₹1,844.59Cr (-)₹1,829.47Cr (↓0.82%)₹3,120.00Cr (↑70.54%)₹3,106.40Cr (↓0.44%)
Total Liabilities₹562.14Cr (-)₹547.65Cr (↓2.58%)₹705.50Cr (↑28.82%)₹731.90Cr (↑3.74%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹316.76Cr (-)₹608.38Cr (↑92.06%)-₹3.55Cr (↓100.58%)-₹65.10Cr (↑1,733.80%)₹143.20Cr (↓319.97%)

Index Inclusions

BSE Healthcare

₹40,263.69

0.4 (▲159.55%)

S&P BSE 250 SmallCap

₹5,924.26

1.21 (▲71.08%)

Nifty MidSmallcap 400

₹17,400.70

1.28 (▲219.75%)

S&P BSE AllCap

₹10,471.31

0.68 (▲71.07%)

Nifty 500

₹20,831.10

0.48 (▲99.65%)

Nifty Smallcap 250

₹14,767.30

-58.56 (▲-20868.65%)

S&P BSE 400 MidSmallCap

₹10,582.55

1.23 (▲128.5%)

BSE 500

₹32,757.57

0.46 (▲149.8%)

BSE Small-Cap

₹46,054.94

1.32 (▲599.11%)

Jubilant Pharmova Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
50.68%
0.00
Foreign Institutions
16.96%
-5.46
Mutual Funds
3.64%
18.81
Retail Investors
24.83%
-1.33
Others
3.9%
23.43

Jubilant Pharmova Key Indicators

Details20202021202220232024
Return On Assets %15.8245.3122.63-1.962.48
Details20202021202220232024
Book Value Per Share (₹)305.27297.85334.1339.58343.92
Details20202021202220232024
Earning Per Share (₹)48.9352.4925.94-4.084.6
Details20202021202220232024
Return On Equity %12.9811.036.122.71.32

Jubilant Pharmova Valuation

Jubilant Pharmova in the last 5 years

  • Overview

  • Trends

Lowest (-195.50x)

December 29, 2023

Today (24.46x)

February 19, 2025

Industry (51.87x)

February 19, 2025

Highest (257.22x)

February 16, 2024

LowHigh

Jubilant Pharmova Earnings and Dividends

  • Jubilant Pharmova Ltd Earnings Results

    Jubilant Pharmova Ltd’s net profit jumped 51.05% since last year same period to ₹100.90Cr in the Q3 2024-2025. On a quarterly growth basis, Jubilant Pharmova Ltd has generated -1.85% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Jubilant Pharmova Ltd Dividends May,2024

    In the quarter ending March 2024, Jubilant Pharmova Ltd has declared dividend of ₹5 - translating a dividend yield of 1.03%.

    Read More about Dividends

Jubilant Pharmova Technicals Summary

Bearish

Neutral

Bullish

Bullish

Jubilant Pharmova Ltd is currently in a Bullish trading position according to technical analysis indicators.

More on Technical Analysis

Jubilant Pharmova Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd
BUY₹15,427.41 Cr20.84%0.57₹72 Cr₹6,702 Cr
Suven Pharmaceuticals Ltd
Suven Pharmaceuticals Ltd
BUY₹29,528.26 Cr117.66%0.52₹300 Cr₹1,051 Cr
Sun Pharma Advanced Research Company Ltd
Sun Pharma Advanced Research Company Ltd
NA₹4,270.70 Cr-4.25%0.79-₹388 Cr₹75 Cr
Rainbow Childrens Medicare Ltd
Rainbow Childrens Medicare Ltd
BUY₹13,039.23 Cr37.04%0.68₹218 Cr₹1,296 Cr
Poly Medicure Ltd
Poly Medicure Ltd
BUY₹22,333.20 Cr117.58%0.55₹258 Cr₹1,375 Cr
See all

About Jubilant Pharmova

Jubilant Pharmova Ltd is a well-established and leading pharmaceutical company, listed on the Stock Exchange of India. It provides world-class and innovative products and solutions to its customers in the Indian and global markets. It has a sound and strong presence in both the domestic and international markets. The company is focused towards delivering excellent quality healthcare solutions with the highest standards of safety and efficacy. It has implemented stringent quality management systems as well as advanced research and development activities, which enable them to produce quality products meeting all applicable regulatory requirements. With its strong commitment towards delivering excellence, the company takes pride in setting a benchmark in the pharmaceutical industry.

Share Price: ₹991.05 per share as on 20 Feb, 2025 04:01 PM
Market Capitalisation: ₹15,427.41Cr as of today
Revenue: ₹1,813.70Cr as on December 2024 (Q4 24)
Net Profit: ₹100.70Cr as on December 2024 (Q4 24)
Listing date: 09 Nov, 1994
Chairperson Name: Shyam S Bhartia
OrganisationJubilant Pharmova
HeadquartersNoida
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Jubilant Pharmova Ltd

What is Jubilant Pharmova Ltd price today?

Jubilant Pharmova Ltd share price today stands at ₹991.05, Open: ₹960.1, Previous Close: ₹968.45, High: ₹1004.45, Low: ₹959.3, 52 Week High: ₹1309.9, 52 Week Low: ₹538.05.

How to Buy Jubilant Pharmova Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Jubilant Pharmova Ltd shares

Is Jubilant Pharmova Ltd listed on NSE?

Jubilant Pharmova Ltd is listed on NSE

Is Jubilant Pharmova Ltd listed on BSE?

Jubilant Pharmova Ltd is listed on BSE

What are today's High and Low prices of Jubilant Pharmova Ltd?

  • Today's highest price of Jubilant Pharmova Ltd is ₹1004.45.
  • Today's lowest price of Jubilant Pharmova Ltd is ₹959.3.

What are today's traded volumes of Jubilant Pharmova Ltd?

Today's traded volume of Jubilant Pharmova Ltd(JUBLPHARMA) is 1.40L.

What is today's market capitalisation of Jubilant Pharmova Ltd?

Today's market capitalisation of Jubilant Pharmova Ltd(JUBLPHARMA) is ₹15427.41Cr.

What is the 52 Week High and Low Range of Jubilant Pharmova Ltd?

Jubilant Pharmova Ltd (JUBLPHARMA)
Price
52 Week High
₹1309.9
52 Week Low
₹538.05

How much percentage Jubilant Pharmova Ltd is down from its 52 Week High?

Jubilant Pharmova Ltd (JUBLPHARMA) share price is ₹991.05. It is down -24.34% from its 52 Week High price of ₹1309.9

How much percentage Jubilant Pharmova Ltd is up from its 52 Week low?

Jubilant Pharmova Ltd (JUBLPHARMA) share price is ₹991.05. It is up 84.19% from its 52 Week Low price of ₹538.05

What are the historical returns of Jubilant Pharmova Ltd?

Jubilant Pharmova Ltd (JUBLPHARMA)
Returns
1 Day Returns
22.6%
1 Month Returns
-1.39%
3 Month Returns
-14.32%
1 Year Returns
61.19%

What is the PE ratio of Jubilant Pharmova Ltd today?

PE Ratio of Jubilant Pharmova Ltd is 24.46

PE ratio = Jubilant Pharmova Ltd Market price per share / Jubilant Pharmova Ltd Earnings per share